Tag: bioMérieux
bioMérieux: CE marking for its blood test against head trauma – 10/13/2023 at 10:03
(AOF) – bioMérieux announces the CE marking of VidasTBI, a blood test for the evaluation and management of patients with mild head trauma. The in vitro diagnostic specialist specifies that…
Biomerieux: Well oriented with comments from brokers
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
bioMérieux: well oriented with comments from brokers
(CercleFinance.com) – bioMérieux gains 2% and thus outperforms the trend in Paris, supported by favorable remarks from brokers after the publication of the results of the in vitro diagnostics group…
bioMérieux: many advantages in hand
By Jean-Baptiste Andre Published on 08/21/2023 at 1:51 p.m. TP ICAP Midcap reiterates its ‘buy’ advice and its target of 109 euros on bioMerieux…
bioMérieux: stock on the rise, a broker raises its board
(CercleFinance.com) – bioMérieux gained nearly 2% on the Paris stock exchange after Oddo BHF raised its recommendation on the stock from ‘neutral’ to ‘outperforming’ and bringing it into its ‘European…
bioMérieux: in the green with an analyst increase
(CercleFinance.com) – bioMérieux gained more than 1% with the support of Oddo BHF, which went from ‘neutral’ to ‘outperforming’ and included it in its ‘European midcap list’, with a price…
bioMérieux: Oddo BHF raises its opinion
(CercleFinance.com) – Oddo BHF which goes from ‘neutral’ to ‘outperforming’ on bioMérieux and brings it into its ‘european midcap list’, with a price target maintained at 105 euros, given the…
In its Lyon region, bioMérieux secures its supplies
A bioMérieux employee works on the site of the Marcy l’Etoile pharmaceutical company near Lyon, June 20, 2023 (AFP / JEFF PACHOUD) Attached to its industrial roots in Lyon but…
bioMérieux: functions of Chairman and CEO separated – 06/14/2023 at 08:40
(CercleFinance.com) – bioMérieux announces a change in its governance: as of July 1, Alexandre Mérieux will become executive chairman and Pierre Boulud, chief executive officer (CEO), appointments validated on June…
bioMérieux: functions of Chairman and CEO separated
(CercleFinance.com) – bioMérieux announces a change in its governance: as of July 1, Alexandre Mérieux will become executive chairman and Pierre Boulud, chief executive officer (CEO), appointments validated on June…
bioMérieux separates the functions of Chairman and Chief Executive Officer – 06/14/2023 at 09:11
(AOF) – bioMérieux has announced a change in the governance of the company. As of July 1, 2023, Alexandre Mérieux becomes Executive Chairman and Pierre Boulud Chief Executive Officer. Pierre…
bioMérieux: CLIA waiver for a breath test – 05/10/2023 at 08:40
(CercleFinance.com) – bioMérieux announces that it has obtained a CLIA waiver from the US FDA for its Biofire Spotfire (R) Panel Mini PCR multiplex breath test, a waiver in addition…